ISO 4802-1:2023
Glassware — Hydrolytic resistance of the interior surfaces of glass containers — Part 1: Determination by titration method and classification
Glassware — Hydrolytic resistance of the interior surfaces of glass containers — Part 1: Determination by titration method and classification
- Статус документа:
- Действующий
- Формат:
- Электронный (PDF)
- Количество страниц:
- 13
- Дата публикации:
- 4 декабря 2023 г.
- Издание:
- ISO IS 4802 edition 4 version 1
- ICS:
- 71.040.20
This document specifies: a) a method for determining the hydrolytic resistance of the interior surfaces of glass containers when subjected to attack by water at (121 ± 1) °C for (60 ± 1) min. The resistance is measured by titration of a known aliquot portion of the extraction solution produced with hydrochloric acid solution, in which case the resistance is inversely proportional to the volume of acid required; b) a classification of glass containers according to the hydrolytic resistance of the interior surfaces determined by the methods specified in this document.
Abstract
Overview
ISO 4802-1:2023 - Glassware - Hydrolytic resistance of the interior surfaces of glass containers - Part 1: Determination by titration method and classification defines a standardized laboratory test and classification scheme for the hydrolytic resistance of interior glass surfaces. The method exposes filled containers to water at (121 ± 1) °C for (60 ± 1) min, measures released alkaline species in the extraction solution by titration with hydrochloric acid, and classifies containers (HC 1, HC 2, HC 3, HC B, HC D) according to the measured response. The procedure is intended for as-produced containers and aligns key aspects with the European Pharmacopoeia for improved reproducibility.
Key technical topics and requirements
- Test principle: Surface test where containers are filled with specified water, loosely capped, autoclaved under defined conditions, then analyzed by titration of an aliquot of the extraction solution. Hydrolytic resistance is inversely proportional to the acid volume required.
- Autoclaving conditions: Precisely defined cycle at 121 °C for 60 minutes to simulate hydrolytic attack (document specifies detailed cycle to increase interlaboratory reproducibility).
- Sample preparation: Requirements for sample size, determination of filling volume (procedures for different container geometries such as ampoules, syringes, round- or flat‑bottomed containers), and cleaning prior to testing.
- Analytical method: Titration reagents and apparatus, aliquoting, and calculation of released alkali-reacting ions; expression of results and reporting.
- Classification and designation: Defined container classes (HC 1, HC 2, HC 3, HC B, HC D) and guidance on distinguishing classes (notably HC 1 vs HC 2), including applicability to parenteral and non-parenteral preparations.
- Quality aspects: Requirements for test reporting, reproducibility data, and a formal classification table for container-specific limits.
Practical applications - who uses this standard
- Pharmaceutical glass-container manufacturers (bottles, vials, ampoules, syringes, cartridges) for product development and quality control.
- Medical device and packaging engineers specifying primary packaging for parenteral and non-parenteral formulations.
- Quality control and analytical laboratories performing hydrolytic-resistance testing and batch release.
- Regulatory and compliance teams relying on objective classification (HC classes) to demonstrate suitability of glassware for specific pharmaceutical applications.
- Procurement and materials specialists selecting glass types (e.g., borosilicate, soda-lime-silica) and surface treatments.
Related standards
- ISO 719, ISO 720 (glass hydrolytic resistance of grains)
- ISO 385, ISO 648, ISO 1773, ISO 3819 (laboratory glassware and apparatus)
- ISO 9187-1 (ampoules for injectables)
- European Pharmacopoeia and USP <660> (related classification principles)
ISO 4802-1:2023 is a practical, reproducible reference for assessing hydrolytic durability of glass containers and ensuring suitable packaging performance for pharmaceutical and medical applications.
Технические детали
- Технический комитет
- ISO/TC 76 - Transfusion, infusion and injection, and blood processing equipment for medical and pharmaceutical use
- SKU
- ISO 4802-1:2023
Похожие стандарты
Стандарты, упомянутые в описании
ISO 7195:2005
ОтменёнNuclear energy — Packaging of uranium hexafluoride (UF6) for transport
ISO 7206-1:1995
ОтменёнImplants for surgery — Partial and total hip joint prostheses — Part 1: Classification and designation of dim…
ISO 3856-1:1984
ДействующийPaints and varnishes — Determination of "soluble" metal content — Part 1: Determination of lead content — Fla…
Overview ISO 3856-1:1984 is an international standard published by the International Organization for Standardization (ISO) that specifies methods for determining the "soluble" lead content in paints…
ISO 6481:2019
ДействующийTest conditions for vertical surface type broaching machines — Testing of accuracy
Overview ISO 6481:2019 - Test conditions for vertical surface type broaching machines - Testing of accuracy - specifies geometric accuracy tests and tolerances for vertical surface type broaching mac…
ISO 17734-2:2013
ДействующийDetermination of organonitrogen compounds in air using liquid chromatography and mass spectrometry — Part 2:…
Overview ISO 17734-2:2013 specifies a validated laboratory and field procedure for the sampling and analysis of airborne amines and aminoisocyanates in workplace air. The method uses derivatization w…
ISO 3819:2015
ДействующийLaboratory glassware — Beakers
Overview ISO 3819:2015 - Laboratory glassware - Beakers defines an internationally accepted series of glass beakers for laboratory use. It specifies types, capacities, materials, dimensional requirem…
ISO 9187-1:2010
ДействующийInjection equipment for medical use — Part 1: Ampoules for injectables
Overview ISO 9187-1:2010 - "Injection equipment for medical use - Part 1: Ampoules for injectables" specifies requirements for glass ampoules used as primary packaging for injectable pharmaceutical p…